Why the study?
Residual neuromuscular block remains a significant perioperative safety concern and is still widely under-recognized by perioperative healthcare professionals.
Does quantitative neuromuscular monitoring and reversal reduce the risk of residual neuromuscular block in patients undergoing general anesthesia?
Design
Comprehensive review
Authors
Loading...
RNMB under-recognition may heighten postoperative risks; leaves open optimal monitoring implementation strategies.
Does quantitative neuromuscular monitoring and reversal reduce the risk of residual neuromuscular block in patients undergoing general anesthesia?
Residual neuromuscular block remains a significant safety concern, and quantitative monitoring combined with reversal agents like sugammadex is recommended to reduce its incidence.
Blum et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: